BioNTech SE (BNTX)
NASDAQ: BNTX · Real-Time Price · USD
114.83
+10.15 (9.70%)
Apr 23, 2025, 4:00 PM EDT - Market closed
BioNTech SE Stock Forecast
Stock Price Forecast
The 17 analysts with 12-month price forecasts for BioNTech SE stock have an average target of 145.88, with a low estimate of 122 and a high estimate of 172. The average target predicts an increase of 27.04% from the current stock price of 114.83.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for BioNTech SE stock from 17 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Nov '24 | Dec '24 | Jan '25 | Feb '25 | Mar '25 | Apr '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 8 | 8 | 9 | 9 | 10 | 10 |
| Buy | 3 | 4 | 4 | 4 | 4 | 4 |
| Hold | 3 | 3 | 3 | 3 | 3 | 3 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 14 | 15 | 16 | 16 | 17 | 17 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $150 → $145 | Strong Buy | Maintains | $150 → $145 | +26.27% | Apr 1, 2025 |
| Citigroup | Citigroup | Strong Buy Initiates $145 | Strong Buy | Initiates | $145 | +26.27% | Mar 13, 2025 |
| Morgan Stanley | Morgan Stanley | Buy Maintains $145 → $139 | Buy | Maintains | $145 → $139 | +21.05% | Mar 11, 2025 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $171 | Strong Buy | Maintains | $171 | +49.30% | Mar 11, 2025 |
| BMO Capital | BMO Capital | Buy Maintains $130 → $143 | Buy | Maintains | $130 → $143 | +24.53% | Mar 11, 2025 |
Financial Forecast
Revenue This Year
2.14B
from 2.75B
Decreased by -22.25%
Revenue Next Year
2.34B
from 2.14B
Increased by 9.21%
EPS This Year
-5.29
from -2.77
EPS Next Year
-4.71
from -5.29
Financial currency is EUR. Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 2.9B | 3.7B | 3.0B | ||
| Avg | 2.1B | 2.3B | 2.4B | ||
| Low | 1.8B | 1.6B | 1.7B |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 4.3% | 73.9% | 30.5% | ||
| Avg | -22.2% | 9.2% | 1.4% | ||
| Low | -35.7% | -24.0% | -26.5% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -2.43 | -1.26 | -0.20 | ||
| Avg | -5.29 | -4.71 | -4.93 | ||
| Low | -7.60 | -8.58 | -9.32 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.